Background
A CDMO supporting a Top 5 pharmaceutical sponsor facing a critical late-stage supply chain failure.
The challenge
Just days before dosing, the manufacturer unexpectedly declined a scheduled supply of a high-demand oncology comparator drug. With regulatory requirements including a CoA still to be met, and no time to lose, the CDMO turned to Matrix to safeguard the study.
“Matrix’s agility and dedication to make this critical supply happen on time, in such a short period of time, is what truly sets them apart… no corners were cut and the same high level of service was provided throughout.”
The solution
Matrix mobilised its network within hours, reallocating existing stock from future shipments without compromising other client commitments. We completed full QA checks and documentation within four hours at our German hub, and delivered the shipment using specialist, temperature-assured logistics.
The outcome
Begin your
partnership
with Matrix
